S
The startup develops a medical platform that utilizes computational oncology to create personalized virtual tumors from diagnostic datasets, enhancing the understanding of cancer for healthcare providers. This approach enables more tailored treatment plans, improving patient outcomes in cancer care.
Updated 18 months ago
Funding
$21.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NVFunding rounds are not available yet.
Founders
Product
Features
- The startup develops a medical platform that utilizes computational oncology to create personalized virtual tumors from diagnostic datasets, enhancing the understanding of cancer for healthcare providers. This approach enables more tailored treatment plans, improving patient outcomes in cancer care.